Spinol Medical

Company Overview

Snapshot

Founded in October 2018 by Roey Shafrir, Spinol Medical operates with 1–10 employees. The company has secured funding across one round and is currently in the Seed stage. In December 2025, Spinol Medical advanced its OctaSeal device into FDA review, supported by five-year clinical data.

Business overview

Spinol Medical is a Health Tech & Life Sciences company focused on developing innovative medical devices. The company's core product, OctaSeal, is a novel, minimally invasive annular closure system designed to reduce re-herniation following lumbar discectomy. This implantable device seals ruptured spinal discs and aims to eliminate the risk of reherniation, serving the healthcare sector, particularly hospitals, healthcare providers, and clinics, within the orthopedics and medical devices categories.

Strategic signal

In December 2025, Spinol Medical announced that its OctaSeal device had advanced into FDA review, supported by five-year clinical data. This development signals significant progress in the regulatory pathway for their minimally invasive intradiscal annular closure technology, indicating potential market entry and validation for investors in the medical device and orthopedics sectors.

Company Intelligence Q&A

What is Spinol Medical's primary product?

Spinol Medical's primary product is OctaSeal, a novel, minimally invasive annular closure system designed to reduce re-herniation following lumbar discectomy.

When was Spinol Medical founded?

Spinol Medical was founded in October 2018.

Who is the founder of Spinol Medical?

Roey Shafrir is the founder of Spinol Medical.

What is the current employee count for Spinol Medical?

Spinol Medical currently has 1–10 employees.

What is the latest significant development for Spinol Medical's OctaSeal device?

In December 2025, Spinol Medical advanced its OctaSeal device into FDA review, supported by five-year clinical data.